中文         English  
  产品分类  
原料药
医药中间体
工艺开发产品
定制化学品
优势产品
工艺技术转让
 
   产品搜索
  
      
  
 
 
产品展示 您现在的位置是:首页 >> 产品展示 >> 原料药 
 
ACY-1215
 

ACY-1215 Rocilinostat; ACY1215; ACY 1215) CAS 1316214-52-4

Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM; >10-fold more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight

ACY-1215的生物活性

Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM; >10-fold more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight activity against HDAC8, minimal activity against HDAC4/5/7/9/11, Sirtuin1, and Sirtuin2.
IC50 Value: 5 nM
Target: HDAC6
in vitro: ACY-1215 is a hydroxamic acid derivative. ACY-1215 is 12-, 10-, and 11-fold less active against HDAC1, HDAC2, and HDAC3 (class I HDACs), respectively. ACY-1215 has minimal activity (IC50 > 1μM) against HDAC4, HDAC5, HDAC7, HDAC9, HDAC11, Sirtuin1, and Sirtuin2, and has slight activity against HDAC8 (IC50 = 0.1μM). The IC50 values for ACY-1215 for T-cell toxicity is 2.5μM. ACY-1215 overcomes tumor cell growth and survival conferred by BMSCs and cytokines in the BM milieu. ACY-1215 in combination with bortezomib induces synergistic anti-MM activity. ACY-1215 induces potent acetylation of α-tubulin at very low doses and triggers acetylation of lysine on histone H3 and histone H4 only at higher doses, confirming its specific inhibitory effect on HDAC6 activity.
in vivo: ACY-1215 in combination with bortezomib triggered more significant anti-MM activity than either agent alone in suppressing tumor growth and prolonging survival in both plasmacytoma model and disseminated MM model without significant adverse effects. ACY-1215 is readily absorbed by tumor tissue. Moreover, the drug does not accumulate in tumor tissue, as evidenced by the parallel decline of acetylated α-tubulin in blood cells and tumor tissue by 24 hours after dose.

化学信息

分子量 433.5 储存条件 参考CoA中推荐的条件进行储存。
分子式 C24H27N5O3
CAS号 1316214-52-4
溶剂/溶解度 DMSO 85 mg/ml; Water <1 mg/ml

返回上一页
 
关于我们 | 产品展示 | 新闻中心 | 设备展示 | 客户留言 | 联系我们 版权所有:上海凯裕医药科技有限公司  技术支持网至普网站建设